HSPD1 (Heat Shock Protein Family D (Hsp60) Member 1)

This article provides a detailed review of the current research status and progress regarding the pathogenic mechanisms of chaperonins in human diseases, related drug development, and clinical applications. It aims to offer basic researchers, drug developers, and clinicians a perspective on diseases through the lens of chaperonins, thereby promoting the translation of related research findings into clinical applications.

Thus, HSF1 safeguards the cancer proteome to enable the oncogenic potential of mTORC1. This proof-of-principle study highlights provoking proteomic catastrophe as a next-generation therapeutic concept for combating malignancy.

The HSS-F2 resulted in improved welfare, and data suggest that adjustments be made for chick head size differences. This study is the first to identify a non-invasive method for measuring stress and inflammatory biomarkers in chick down feathers.

Chemosensitivity analysis showed that the high-risk group had increased sensitivity to four drugs, including Axitinib, but decreased sensitivity to 21 drugs, including Cisplatin...Molecular docking revealed that five compounds, including Oseltamivir, could bind directly to NEU1. Knockdown of NEU1 significantly reduced proliferation, migration, and invasion of LIHC cells, and slowed LIHC tumor growth. We constructed a histone acetylation-based risk model for LIHC diagnosis, prognosis, and therapy, identifying NEU1 as a key biomarker and potential therapeutic target.

This study demonstrates LukS-PV targets C5aR to inhibit HCC EMT via the BCL6/HDAC6/HSPD1 axis, highlighting its potential as an HCC therapeutic agent. These findings provide valuable EMT regulatory insights and identify potential HCC therapeutic targets.

Further analysis indicated that NAT10 overexpression enhanced the stability and expression of HSPD1 through increased N4-acetylcytidine (ac4C) modification, thereby exerting its effects by interacting with HSPD1. These findings highlight the pivotal role of the LINC00942/NAT10/HSPD1 axis in ESCA development, suggesting it as a potential biomarker and therapeutic target for the disease.

siRNA@EVs achieved significant HSPD1 silencing, effectively inhibiting the proliferation and metastasis of PCa cells, and blocking xenografts tumor growth in nude mice with safety. siRNA@EVs targeting HSPD1 demonstrate precision therapeutic potential with robust efficacy and safety, offering a novel approach for targeted therapy in PCa.

Triptolide may induce male germ cell damage, and DMGCs and germ cell components lead to non-infectious epididymitis. The findings provided novel insights into the mechanisms behind triptolide-induced male infertility and can aid in developing preventive and therapeutic strategies to address this side effect.

This review describes known interactions among mediators of the UPRmt pathway and how they may be dysregulated in cancer cells. We also explore how this altered stress response may provide avenues for therapeutic targeting.

Our findings highlighted the relationship between HS, the onset of orchitis, and the activation of the complement system, all of which decreased the boar semen quality.

These findings indicate that C. perfringens may promote FLD by impairing gut barrier integrity and enhancing inflammatory responses. In conclusion, our findings suggest that C. perfringens may contribute to the development of FLD in dairy cows by impairing intestinal barrier integrity and promoting systemic inflammation.